All-Access Pass

All CME lectures available on the Academy are included in this package (over 400 hours of education).

For one year, get access to 100% of the clinical content available on the Obesity Medicine Academy at an unbeatable discounted rate! Earn CME/CE credit and gain crucial knowledge and clinically applicable treatment strategies, all while learning from industry thought leaders, published journal authors, and your colleagues in the field of obesity medicine. 

 

Search by Category
Search by Format
Sort By
  • Includes Credits

    Sandra Christensen MSN, ARNP, FNP-BC, FOMA

    CME/CE Expiration Date: 1/25/2026* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Sarcopenic obesity presents numerous risks to health and quality of life. Those with low lean muscle mass and function and increased adiposity are at risk for significant adverse health consequences, disability, frailty, and increased mortality. While it is more prevalent in older adults, adults of all ages are affected, with an overall prevalence of 15.9% of the U.S. population. Early diagnosis and treatment are vital to preserving and improving the health of those affected. In this webinar, you will learn how to identify and manage patients with sarcopenic obesity, as well as those at risk. 

     Objectives:

    1. Describe the pathophysiology and adverse health consequences of sarcopenic obesity

    2. Identify individuals who have or are at risk for sarcopenic obesity

    3. Utilize treatment strategies that increase lean muscle mass and function, reduce health risks, and improve health and quality of life

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes a Live Web Event on 02/21/2023 at 7:00 PM (EST)

    Sponsored by the OMA Advocacy Committee Presented by Dr. Rebecca Andrick Panelists include: Chris Gallagher, Dr. Verlyn Warrington, Dr. Vicki March, Dr. Leslie Golden, Dr. Laura Davisson , and Dr. Michael McClurkan

    This is a Non-CME webinar. 

    Sponsored by the OMA Advocacy Committee
    Presented by Dr. Rebecca Andrick 
    Panelists include: Chris Gallagher, Dr. Verlyn Warrington, Dr. Vicki March, Dr. Leslie Golden, Dr. Laura Davisson , and Dr. Michael McClurkan    


    Description:   This webinar will review the obesity medicine clinician’s role in advocacy efforts as it relates to patient access to AOMs on both a macro as well as micro level.  Through a panel-based discussion based on lived experience in their various practice locales, participants will hear from key members of the OMA’s Advocacy Committee including remarks from Chris Gallagher, the OMA’s consultant on advocacy and policy matters.  


     Objectives: 

    1. Verbalize the available resources to both obesity medicine clinicians and their patients as it relates to advocacy for anti-obesity medications (AOMs) and other treatments for obesity.
    2. Identify potential partnerships within health systems, local, state, and federal agencies for which to advocate for access to obesity treatment.
    3. Understand the impact of implicit bias and obesity as it relates to access to care for patients.   

     

     

     


  • Includes Credits

    Sandra Christensen MSN, ARNP, FNP-BC, FOMA

    CME/CE Expiration Date: 1/25/2026* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Sarcopenic obesity presents numerous risks to health and quality of life. Those with low lean muscle mass and function and increased adiposity are at risk for significant adverse health consequences, disability, frailty, and increased mortality. While it is more prevalent in older adults, adults of all ages are affected, with an overall prevalence of 15.9% of the U.S. population. Early diagnosis and treatment are vital to preserving and improving the health of those affected. In this webinar, you will learn how to identify and manage patients with sarcopenic obesity, as well as those at risk. 

     Objectives:

    1. Describe the pathophysiology and adverse health consequences of sarcopenic obesity

    2. Identify individuals who have or are at risk for sarcopenic obesity

    3. Utilize treatment strategies that increase lean muscle mass and function, reduce health risks, and improve health and quality of life


    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits Includes a Live Web Event on 02/16/2023 at 12:00 PM (EST)

    Justin Tondt., M.D.

    CME/CE Expiration Date: 2/16/2026* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    Clinicians are likely familiar with total energy expenditure being comprised of resting energy expenditure, diet induced thermogenesis, and physical activity. However, there are other less well-known factors that affect total energy expenditure, complicating both its estimation and measurement.  The goal of this session is to familiarize participants with several of these factors using a case-based format. 

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits Includes a Live Web Event on 02/09/2023 at 11:00 AM (EST)

    Carl Lavie, JR., M.D., FACC, FACP, FCCP

    CME/CE Expiration Date: 2/9/2026* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    In this webinar, Dr  Carl Lavie will discuss the adverse effects that obesity has on the major CVD risk factors and to increase almost all CVD. However, despite these facts, patients with obesity and established CVD often have a better short and medium-term prognosis than do leaner patients with the same CVD. This is termed the obesity paradox. Considering this, Dr Lavie will also discuss the potential for weight reduction, especially with increased levels of physical activity and exercise that also increases cardiorespiratory fitness (CRF) and discuss the role of CRF on the obesity paradox. 

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    Eric Westman, MD, MHS, MFOMA and Justin Tondt, MD, Andres Acosta, MD, PhD

    Nutrition Q&A 

  • Includes Credits

    Jamy Ard, M.D.

    CME/CE Expiration Date: 12/14/2025* 

    *The expiration date listed above is the last day CME/CE credit can be claimed for this specific presentation.

    Description: 

    As the choices available for anti-obesity pharmacotherapy increase, clinicians are faced with options for addressing key clinical scenarios. Understanding factors that impact treatment response and how one might tailor treatment can improve treatment outcomes. Jamy Ard M.D. will review what we know and don't know in some common clinical scenarios seen in everyday practice.

    Accreditation: 

    The Obesity Medicine Association is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Obesity Medicine Association designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Includes Credits

    One of the limitations of BMI is that it fails to account for either body composition or body fat distribution. While patients with lipedema may have a BMI >30kg/m2, their condition is very different from most obesity associated with positive energy balance. Accumulation of fibroadipose tissue in the lower body and arms has distinct pathologic features as well as resistance to conventional therapies. This session will examine how lipedema is different from most forms of obesity, how it is diagnosed, and the unique treatment strategies used to combat this challenging condition.

    Speaker: Karen Herbst, MD, PhD

    Description: One of the limitations of BMI is that it fails to account for either body composition or body fat distribution. While patients with lipedema may have a BMI >30kg/m2, their condition is very different from most obesity associated with positive energy balance. Accumulation of fibroadipose tissue in the lower body and arms has distinct pathologic features as well as resistance to conventional therapies. This session will examine how lipedema is different from most forms of obesity, how it is diagnosed, and the unique treatment strategies used to combat this challenging condition.

    Learning Objectives:

    Define lipedema and distinguish it from other adiposity-related disorders

    Discuss the Standards of Care for Lipedema in the US

    Describe the role of supplements, nutrition, manual therapy, and surgery in lipedema treatment

    Utilize effective treatment strategies for patients with lipedema

  • Includes Credits

    The treatment approaches to obesity care often give little regard to gender specific needs in weight management. Nutritional, behavioral, and physical activity treatments vary widely between gender across the lifespan. Daniela Hurtado Andrade, MD, PhD will highlight key differences in the pathophysiology of obesity between men and women and how those difference impact obesity treatment.

    The treatment approaches to obesity care often give little regard to gender specific needs in weight management.  Nutritional, behavioral, and physical activity treatments vary widely between gender across the lifespan. Daniela Hurtado Andrade, MD, PhD  will highlight key differences in the pathophysiology of obesity between men and women and how those difference impact obesity treatment.


    Learning Objectives:

    Identify the pathophysiologic differences of obesity in men and women.

    Consider gender specific metabolic and psychologic needs across the lifespan

    Describe the limitations of obesity research in men and women

    Utilize gender specific therapies for obesity

  • Includes Credits

    The Obesity Medicine Association (OMA) is a science leader regarding clinical obesity medicine. OMA has published several Clinical Practice Statements via its journal - Obesity Pillars. The intent of these CPS is to help clinicians manage patients with obesity. This session will provide a brief overview of some of the more recent OMA Clinical Practice Statements.

    • Speaker: Harold Bays, MD, FOMA, FTOS, FACC, FNLA, FASPC
    • Description: The Obesity Medicine Association (OMA) is a science leader regarding clinical obesity medicine. OMA has published several Clinical Practice Statements via its journal - Obesity Pillars. The intent of these CPS is to help clinicians manage patients with obesity. This session will provide a brief overview of some of the more recent OMA Clinical Practice Statements.
    • Learning Objectives:
      • Describe the basic concepts regarding Clinical Practice Statements (CPS) published by the Obesity Medicine Association OMA
      • Identify contents location of OMA CPS.
      • Utilize the resources provided by CPS and the Obesity Pillars